Multimorbidity and Mortality Models to Predict Complications Following Percutaneous Coronary Interventions

Mandeep Singh1, Rajiv Gulati1, Bradley R Lewis2

  • 1Department of Cardiovascular Medicine (M.S., R.G., M.A., P.F., M.R.B.), Mayo Clinic, Rochester, MN.

Insights

New percutaneous coronary intervention (PCI) risk models predict in-hospital mortality, bleeding, acute kidney injury, and stroke. These validated models offer valuable prognostic information for patients and physicians, improving PCI care.

Area of Science:

  • Cardiovascular Medicine
  • Medical Informatics
  • Health Outcomes Research

Background:

  • Existing percutaneous coronary intervention (PCI) risk models often focus on single outcomes, limiting their clinical utility.
  • There is a need for comprehensive risk assessment tools that predict multiple adverse events following PCI.
  • This study addresses the limitations of single-outcome models by developing multi-outcome risk prediction tools.

Purpose of the Study:

  • To develop and validate contemporary risk models for percutaneous coronary intervention (PCI).
  • To predict in-hospital mortality, post-procedure bleeding, acute kidney injury, and stroke using a common set of variables.
  • To provide clinicians with improved prognostic and therapeutic information for PCI patients.

Main Methods:

  • Logistic regression models were developed using data from the Mayo Clinic registry (2000-2016) for patients undergoing their first PCI.
  • Two sets of models were created: one using only precatheterization variables (Model B) and another including procedural and angiographic variables (Model A).
  • Model performance was assessed using C statistics and validated through bootstrap analysis and calibration curves across various patient subgroups.

Main Results:

  • The developed risk models demonstrated strong predictive accuracy for in-hospital death (C-statistics 0.90-0.92), bleeding (0.67-0.70), acute kidney injury (0.76-0.77), and stroke (0.71).
  • Bootstrap analysis confirmed the models were not overfit, and calibration curves showed good agreement between predicted and observed outcomes.
  • The models proved robust across diverse patient populations, including those with acute coronary syndrome, cardiogenic shock, diabetes, women, and the elderly.

Conclusions:

  • New risk scoring models, utilizing both precatheterization and procedural/angiographic variables, accurately predict multiple adverse outcomes after PCI.
  • These models offer a significant advancement over single-outcome predictors, providing comprehensive risk assessment.
  • The ease of application of these models will enhance prognostic guidance and therapeutic decision-making for both patients and physicians.
Abstract

Related Concept Videos

Multicompartment Models: Overview01:14

Multicompartment Models: Overview

Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
243
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
27
Two-Compartment Open Model: Overview01:05

Two-Compartment Open Model: Overview

Multicompartmental models are crucial tools in pharmacokinetics, providing a framework to understand how drugs move within the body. The two-compartment model is a crucial subtype, segmenting the body into central and peripheral compartments. The central compartment represents areas with high blood flow, such as plasma and highly perfused organs like the kidneys and liver, while the peripheral compartment signifies tissues with lower blood flow, like adipose tissue and muscle tissue.
The...
231
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
153
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K